Evidence reference only. Not medical advice, not a dosing guide, and not a recommendation to use any drug.
Echo The Echo Compendium
<- Home

The drug roster

40 medicines and 5 combination regimens. Class, physiology and reference records are kept out of this roster.

GLP-1 receptor agonists

18 agents

Semaglutide

MARKETED

GLP-1 receptor agonist

99 results + 2 ongoing View profile ->

Liraglutide

MARKETED

GLP-1 receptor agonist

35 results View profile ->

Dulaglutide

MARKETED

GLP-1 receptor agonist

23 results View profile ->

Exenatide

MIXED STATUS

Exendin-4-based GLP-1 receptor agonist

8 results View profile ->

Ecnoglutide

MARKETED

Long-acting cAMP-biased GLP-1 receptor agonist

5 results View profile ->

LY3537021

INVESTIGATIONAL

Selective long-acting GIP receptor agonist

5 results View profile ->

Lixisenatide

WITHDRAWN

Exendin-4-based GLP-1 receptor agonist

3 results View profile ->

Albiglutide

WITHDRAWN

GLP-1 receptor agonist

2 results View profile ->

Efpeglenatide

INVESTIGATIONAL

Exendin-based GLP-1 receptor agonist

2 results View profile ->

Monlunabant

INVESTIGATIONAL

Peripherally restricted cannabinoid CB1 receptor inverse agonist

2 results View profile ->

Bimagrumab

INVESTIGATIONAL

Activin type II receptor monoclonal antibody

1 results View profile ->

LY3463251

DISCONTINUED

Long-acting GDF15 receptor agonist acting through GFRAL and RET

1 results View profile ->

Resmetirom

MARKETED

Thyroid hormone receptor beta agonist

1 results View profile ->

Setmelanotide

MARKETED

Melanocortin-4 receptor agonist

1 results View profile ->

Apitegromab

INVESTIGATIONAL

Monoclonal antibody that inhibits activation of pro- and latent myostatin

0 results View profile ->

Enobosarm

INVESTIGATIONAL

Selective androgen receptor modulator

0 results View profile ->

Garetosmab

INVESTIGATIONAL

Activin A monoclonal antibody

0 results View profile ->

Trevogrumab

INVESTIGATIONAL

Myostatin monoclonal antibody

0 results View profile ->

Oral and small-molecule GLP-1

6 agents

Combination regimens

5 agents

GLP-1 / glucagon dual agonists

5 agents

GIP / GLP-1 dual agonists

4 agents

Amylin and amylin combinations

4 agents

Triple agonists

3 agents